Ep0034 129 — Dallas, Texas

Ep0034 129 is a clinical research site located in Dallas, Texas, United States 75235.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Ep0034 129 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB BIOSCIENCES, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

• Medical City Spine Hospital - Southwest Scoliosis Institute
• Baylor Scott and White Heart and Vascular Hospital-Dallas
• University Texas Southwestern INT
• VA Medical Center
• Baylor Scott & White The Heart Hospital - Dallas
• MDRI Baylor University
• Baylor Research University Medical Center
• The University of Texas Southwestern Medical Center-IDS Aston Pharmacy
• The University of Texas Southwestern Medical Center in Dallas
• University of Texas Southwestern Medical Center-Parkland Hospital
• Site 19: University of Texas Southwestern
• Baylor Research Institute/Baylor Sammons Cancer Center/Baylor University Medical Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ep0034 129?

Ep0034 129 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ep0034 129 conducted?

Ep0034 129 has 1 clinical trials on record. Their work covers Epilepsy.

Is Ep0034 129 accredited by Crixeo Clinical Trials?

Ep0034 129 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ep0034 129?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.